Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20050998HPVENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS20065483HPVENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44031243HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44008044HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44020668HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44036283HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TCGA Plot Options
Drug Information
GeneFLT3
DrugBank IDDB11763
Drug NameMomelotinib
Target IDBE0000147
UniProt IDP36888
Regulation Typeinhibitor
PubMed IDs34768286
CitationsAzhar M, Kincaid Z, Kesarwani M, Ahmed A, Wunderlich M, Latif T, Starczynowski D, Azam M: Momelotinib is a highly potent inhibitor of FLT3-mutant AML. Blood Adv. 2022 Feb 22;6(4):1186-1192. doi: 10.1182/bloodadvances.2021004611.
GroupsApproved; Investigational
Direct ClassificationPhenylpyrimidines
SMILESO=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1
Pathways
PharmGKB
ChEMBLCHEMBL1078178